Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-12

Clinical Trial Update: A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease [Phase 2]

View source ↗

Summary

Phase 2 trial investigating intravenous fish oil in children with cholestasis was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intravenous fish oil (intravenous fish oil)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Cholestasis | Phase 2 | Status: TERMINATED | Results posted: 2020-02-12